Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.
Daniel Abdullah, PharmD candidate
Advertisement
Articles by Daniel Abdullah, PharmD candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season
2
What Heidi Overton's FDA Nomination Could Mean for Pharmacy
3
Oral vs Intravenous Treatment Logistics
4
FDA Approves First Oral Drug for Dermatomyositis
5